Skip to content

rTMS-stroke-phase I

Therapeutic repetitive Transcranial Magnetic Stimulation in patients with stroke

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
RPCEC
Registry ID
RPCEC00000076
Enrollment
30
Registered
2009-05-29
Start date
2008-05-25
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Thirty hospitalized patients were selected and randomized assigned to 6 different groups. Each one will receive a different transcranial magnetic repetitive stimulation scheme based on stimulation fre

Sponsors

International Center for Neurological Restoration
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with only one stroke from the middle cerebral artery territory and hemiparesia as a sequel Three months or even more of evolution time after stroke Patients hospitalized to be included in the CIREN´s neurological restorative program

Exclusion criteria

Exclusion criteria: Patient with more than one clinical recognized stroke Antecedent of convulsive crisis or presence of active epileptiform activity in the electroencephalogram(EEG)(definned qualitatively by a frequent paroxismal activity and/or high frequency discharges in the conventional EEG, according to expert criteria. Severe congnitive dysfunction that make difficult patient´s collaboration Younger that 18 Pregnant woman Use of electromagnetic prosthesis, like auditive prosthesis or cardiac pacemaker; surgical clips, or any other metallic piece in the head If one or more results from laboratory studies give us new data no suspected from the clinical examination that constitutes a contraindication for the use of this method If in the current condition of the patient, it´s comorbility with other diseases or systemic clinical conditions, the occurrence of a convulsion would deteriorate its health state Even when the investigators do not indentify a contraindication, if it is considered that the patient will not be beneficiated from the treatment for any other reason will be excluded too.

Design outcomes

Primary

MeasureTime frame
Percentage of patients that no fulfill the complete treatment, during the 20 days Percentage of patients who suffer convulsions, after discharges o spread of excitation, during the 20 days of treatment Percentage of patients who suffer headache, cervicalgia o other minor symptom during the 20 days of treatment

Secondary

MeasureTime frame
Incidence of epileptiform discharges and its frequency, before and after to complete 20 sessions of rTMS Barthel´s index, before and after treatment, 3 months, 6 and 12 months Scandinavian Scale for Stroke, before and after treatment, 3 months, 6 and 12 months MRC, before and after treatment, 3 months, 6 and 12 months Hamilton Scale, before and after treatment, 3 months, 6 and 12 months

Countries

Cuba

Contacts

Public ContactDr. Lázaro Gómez Fernández

International Center for Neurological Restoration

lazarog@neuro.ciren.cu

Outcome results

None listed

Source: RPCEC (via WHO ICTRP) · Data processed: Aug 15, 2026